Sutro Biopharma, Inc. (STRO) SEC Filings — 2025
12 SEC filings for Sutro Biopharma, Inc. (STRO) in 2025.
Filings
- Sutro Biopharma Files 8-K — 8-K · Dec 17, 2025
- Sutro Biopharma, Inc. 8-K Filing — 8-K · Dec 3, 2025
- Sutro Biopharma's Losses Mount Amid Deep Restructuring, Nasdaq Threat — 10-Q · Nov 6, 2025
- Sutro Biopharma Reports Exit Costs and Files Exhibits — 8-K · Sep 29, 2025
- Sutro Biopharma's Q2 Loss Widens to $58.1M Amid Revenue Dip — 10-Q · Aug 7, 2025
- Sutro Biopharma Faces Nasdaq Delisting Warning — 8-K · Jun 25, 2025
- Sutro Biopharma Reports on Shareholder Vote Matters — 8-K · Jun 10, 2025
- Sutro Biopharma Appoints New CMO, CFO, and Director — 8-K · Jun 2, 2025
- Sutro Biopharma Files 10-Q, Mentions Astellas Deal — 10-Q · May 8, 2025
- Sutro Biopharma DEF 14A: Executive Equity Awards Detailed — DEF 14A · Apr 25, 2025
- Sutro Biopharma Announces Executive and Director Changes — 8-K · Apr 14, 2025
- Sutro Biopharma Files 2024 10-K, Details Key Partnerships — 10-K · Mar 13, 2025